Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: KalVista Pharmaceuticals Inc (NASDAQ:KALV), MoonLake Immunotherapeutics (NASDAQ:MLTX), CareDx Inc (NASDAQ:CDNA), Pharming Group (NASDAQ:PHAR) and Xencor Inc (NASDAQ:XNCR).
CytomX Therapeutics has a consensus price target of $11.33.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $4.52 last updated April 2, 2026 at 7:15 PM EDT.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.